Neurology Devices Global Market Report 2018

1. Neurology Devices Global Market Report 2018 Including: Neurostimulation Devices; Interventional Neurology; Neurosurgery Devices; Cerebrospinal Fluid (CSF) Management Covering: Medtronic plc, Abbott Lab, B. BraunMelsungen AG, Stryker Corporation, LivaNova Feb 2018

2. Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market. • Report will be updated with the latest data and delivered to you within 3-5 working days of order. Scope Markets Covered: Neurostimulation Devices; Interventional Neurology; Neurosurgery Devices; Cerebrospinal Fluid (CSF) Management Companies Mentioned: Medtronic plc, Abbott Lab, B. BraunMelsungen AG, Stryker Corporation, LivaNova Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa. Time series: Five years historic and forecast. Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, Neurology Devices Indicators Comparison. Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

3. Neurology Devices Neurology Devices Market Characteristics Characteristics Market Neurology devices are designed to aid diagnose, prevent, monitor and treat a variety of neurological disorders and conditions such as Parkinson’s disease, Alzheimer’s disease, epilepsy, major depression, spinal cord and traumatic brain injuries. The neurology devices market is divided into four broad divisions. Cerebrospinal Fluid Management (CSF) Devices are used in the treatment of Interventional Neurology or Neurovascular Devices are used to treat neurovascular diseases such as Neurosurgery Devices are used to perform neurosurgical procedures that are Neurostimulation Devices Market Neurostimulation is a procedure during which In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included. The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.

4. Neurology Devices Neurology Devices Market Historic Growth Historic Growth Market The global neurology devices market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%. The chart and table below shows the year-on-year growth of the global neurology devices market during 2013 – 2017. Drivers of the Market: Restraints on the Market:

5. Neurology Devices Neurology Devices Market Forecast Growth Forecast Growth Market The global neurology devices market is expected to grow from $XX billion in 2017 to $10.2 billion in 2021 at a compound annual growth rate (CAGR) of XX%. The chart and table below shows the year-on-year growth of the global neurology devices market during 2017 - 2021. Drivers of the Market: Restraints on the Market:

6. Neurology Devices Neurology Devices Ma Segmentation Segmentation Market rket The chart and table below shows the split of the neurology devices market in 2017. The total market value for neurology devices was $X billion in 2017. The markets that are covered include Neurostimulation Devices; Interventional Neurology; Neurosurgery Devices; Cerebrospinal Fluid (CSF) Management. Neurostimulation Devices was the X largest segment in the neurology devices market with X% share of the market. The market value for the neurostimulation devices was $X billion in 2017. Interventional Neurology made up around X% share of the market. The market value for the interventional neurology was $X billion in 2017.

7. Neurology Devices Neurology Devices Market Regional And Country Analysis Regional And Country Analysis Market The Asia Pacific was the largest region in the neurology devices market in 2017, neurology devices for $X billion or X% market share. North America was the x largest region neurology devices for $X billion or X% market share. Western Europe was the x largest region neurology devices for $X billion or X% market share.

8. Neurology Devices Neurology Devices Market Competitive Landscape Competitive Landscape Market The leading competitors in the global neurology devices market are Medtronic plc, Abbott Lab, B. BraunMelsungen AG, Stryker Corporation, LivaNova. The chart and table below displays the percentage market share of the top players in the neurology devices market industry. Medtronic, plc generated revenues of $XX billion for the financial year 2016, a XX% increase from the previous year. Abbott Lab generated revenues of $XX billion for the financial year 2016, a XX% increase from the previous year. B. BraunMelsungen AG generated revenues of $XX billion for the financial year 2016, a XX% increase from the previous year. Stryker Corporation generated revenues of $XX billion for the financial year 2016, a XX% increase from the previous year.

9. LivaNova generated revenues of $XX billion for the financial year 2016, a XX% increase from the previous year. Integra LifeSciences Holdings Corp., generated revenues of $XX billion for the financial year 2016, a XX% increase from the previous year. Penumbra, Inc. (U.S.) generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Microport Scientific Corporation generated revenues of $XX billion for the financial year 2016. Company Profile Medtronic plc Overview Medtronic Plc. was the largest company in the neurology devices market with a XX% share of the market in 2017. Medtronic is a medical technology, services and solutions company and serves hospitals, physicians, clinicians and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is headquartered in Dublin, Ireland. Products and Services The company operates through the following divisions- The Cardiac and Vascular division caters to heart health care, which includes The Minimally Invasive Technologies division provides The Restorative Therapies division provides The Diabetes division consists of

10. Strategy Financial Performance Medtronic’s Brain Therapies division involved in neurology devices manufacturing, generated revenues of $XX billion from the neurovascular and neuro modulation segment in 2017, a XX% increase from the previous year. The company had a market Abbott Lab Overview Products and Services Strategy Financial Performance B. BraunMelsungen AG Overview Products and Services Strategy Financial Performance Stryker Corporation Overview Products and Services Strategy Financial Performance LivaNova Overview Products and Services Strategy Financial Performance Medtronic’s growth strategy is to capture untapped business opportunities in emerging markets through public and private partnerships. Medtronic entered into a partnership with